LRRK2 PROTAC Degraders as a Potential Novel Targeting Strategy for Parkinson's Disease? Zimprich A. Mov Disord 2022 Oct 5. doi: 10.1002/mds.29243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zimprich A. LRRK2 PROTAC Degraders as a Potential Novel Targeting Strategy for Parkinson's Disease? Mov Disord 2022 Oct 5. doi: 10.1002/mds.29243.
PMID: 36196588